Evaluation of Speech-Based Digital Biomarkers: Review and Recommendations von Robin, Jessica, Harrison, John E., Kaufman, Liam D., Rudzicz, Frank, Simpson, William, Yancheva, Maria

Volltext

The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease von Colom-Cadena, Marti, Spires-Jones, Tara, Zetterberg, Henrik, Blennow, Kaj, Caggiano, Anthony, DeKosky, Steven T., Fillit, Howard, Harrison, John E., Schneider, Lon S., Scheltens, Phillip, de Haan, Willem, Grundman, Michael, van Dyck, Christopher H., Izzo, Nicholas J., Catalano, Susan M.

Volltext

Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies von Podhorna, Jana, Krahnke, Tillmann, Shear, Michael, Harrison, John E

Volltext

Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration von Jiang, Ying, Alam, John J., Gomperts, Stephen N., Maruff, Paul, Lemstra, Afina W., Germann, Ursula A., Stavrides, Philip H., Darji, Sandipkumar, Malampati, Sandeep, Peddy, James, Bleiwas, Cynthia, Pawlik, Monika, Pensalfini, Anna, Yang, Dun-Sheng, Subbanna, Shivakumar, Basavarajappa, Balapal S., Smiley, John F., Gardner, Amanda, Blackburn, Kelly, Chu, Hui-May, Prins, Niels D., Teunissen, Charlotte E., Harrison, John E., Scheltens, Philip, Nixon, Ralph A.

Volltext

Further validation of the THINC‐it tool and extension of the normative data set in a study of n = 10.019 typical controls von Dalby, Maria, Annas, Peter, Harrison, John E.

Volltext

Cognition comes of age: comments on the new FDA draft guidance for early Alzheimer's disease von Harrison, John E

Volltext

A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease von Prins, Niels D., Harrison, John E., Chu, Hui-May, Blackburn, Kelly, Alam, John J., Scheltens, Philip

Volltext

FDA position statement “Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry” von Sabbagh, Marwan N., Hendrix, Suzanne, Harrison, John E.

Volltext

Commentary: Composite cognitive and functional measures for early stage Alzheimer's disease trials von Harrison, John E.

Volltext

Digital remote assessment of speech acoustics in cognitively unimpaired adults: feasibility, reliability and associations with amyloid pathology von van den Berg, Rosanne L, de Boer, Casper, Zwan, Marissa D, Jutten, Roos J, van Liere, Mariska, van de Glind, Marie-Christine A B J, Dubbelman, Mark A, Schlüter, Lisa Marie, van Harten, Argonde C, Teunissen, Charlotte E, van de Giessen, Elsmarieke, Barkhof, Frederik, Collij, Lyduine E, Robin, Jessica, Simpson, William, Harrison, John E, van der Flier, Wiesje M, Sikkes, Sietske A M

Volltext

Asynchronous Remote Assessment for Cognitive Impairment: Reliability Verification of the Neurotrack Cognitive Battery von Myers, Jennifer Rae, Glenn, Jordan M, Madero, Erica N, Anderson, John, Mak-McCully, Rachel, Gray, Michelle, Gills, Joshua L, Harrison, John E

Volltext

Assessing cognition and daily function in early dementia using the cognitive-functional composite: findings from the Catch-Cog study cohort von Jutten, Roos J, Harrison, John E, Lee Meeuw Kjoe, Philippe R, Ingala, Silvia, Vreeswijk, R, van Deelen, R A J, de Jong, Frank Jan, Opmeer, Esther M, Aleman, André, Ritchie, Craig W, Scheltens, Philip, Sikkes, Sietske A M

Volltext

Screening and measurement of cognitive impairment in psychiatry von Harrison, John E

Volltext

The Cognitive‐Functional Composite is sensitive to clinical progression in early dementia: Longitudinal findings from the Catch‐Cog study cohort von Jutten, Roos J., Harrison, John E., Brunner, A.J., Vreeswijk, R., Deelen, R.A.J., de Jong, Frank Jan, Opmeer, Esther M., Ritchie, Craig W., Aleman, André, Scheltens, Philip, Sikkes, Sietske A.M.

Volltext

No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: a meta-analysis of individual... von Harvey, Philip D, Sabbagh, Marwan N, Harrison, John E, Ginsberg, Henry N, Chapman, M John, Manvelian, Garen, Moryusef, Angele, Mandel, Jonas, Farnier, Michel

Volltext

Which Cognitive Domains are Improved by Treatment with Vortioxetine? von Harrison, John E, Lophaven, Søren, Olsen, Christina K

Volltext

Cognitive Impairment Associated with Cancer: A Brief Review von Pendergrass, J Cara, Targum, Steven D, Harrison, John E

Volltext

Short test of semantic and phonological fluency: Normal performance, validity and test-retest reliability von Harrison, John E., Buxton, Pauline, Husain, Masud, Wise, Richard

Volltext

Cognitive and Functional Change Over Time in Cognitively Healthy Individuals According to Alzheimer Disease Biomarker-Defined Subgroups von Dubbelman, Mark A, Hendriksen, Heleen M A, Harrison, John E, Vijverberg, Everard G B, Prins, Niels D, Kroeze, Lior A, Ottenhoff, Lois, Van Leeuwenstijn, Mardou M S S A, Verberk, Inge M W, Teunissen, Charlotte E, van de Giessen, Elsmarieke M, Van Harten, Argonde C, Van Der Flier, Wiesje M, Sikkes, Sietske A M

Volltext

What's in a Score: A Longitudinal Investigation of Scores Based on Item Response Theory and Classical Test Theory for the Amsterdam Instrumental Activities of Daily Living Question... von Dubbelman, Mark A., Postema, Merel C., Jutten, Roos J., Harrison, John E., Ritchie, Craig W., Aleman, André, de Jong, Frank Jan, Schalet, Benjamin D., Terwee, Caroline B., van der Flier, Wiesje M., Scheltens, Philip, Sikkes, Sietske A. M.

Volltext